Use of the Palliative Performance Scale to Estimate Survival Among Home Hospice Patients with Heart Failure
Open Access
- 5 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 6 (2) , 371-378
Abstract
Aims: Estimating survival is challenging in the terminal phase of advanced heart failure. Patients, families, and health-care organizations would benefit from more reliable prognostic tools. The Palliative Performance Scale Version 2 (PPSv2) is a reliable and validated tool used to measure functional performance; higher scores indicate higher functionality. It has been widely used to estimate survival in patients with cancer but rarely used in patients with heart failure. The aim of this study was to identify prognostic cut-points of the PPSv2 for predicting survival among patients with heart failure receiving home hospice care. Methods and results: This retrospective cohort study included 1114 adult patients with a primary diagnosis of heart failure from a not-for-profit hospice agency between January 2013 and May 2017. The primary outcome was survival time. A Cox proportional-hazards model and sensitivity analyses were used to examine the association between PPSv2 scores and survival time, controlling for demographic and clinical variables. Receiver operating characteristic curves were plotted to quantify the diagnostic performance of PPSv2 scores by survival time. Lower PPSv2 scores on admission to hospice were associated with decreased median (interquartile range, IQR) survival time [PPSv2 10 = 2 IQR: 1–5 days; PPSv2 20 = 3 IQR: 2–8 days] IQR: 55–207. The discrimination of the PPSv2 at baseline for predicting death was highest at 7 days [area under the curve (AUC) = 0.802], followed by an AUC of 0.774 at 14 days, an AUC of 0.736 at 30 days, and an AUC of 0.705 at 90 days. Conclusions: The PPSv2 tool can be used by health-care providers for prognostication of hospice-enrolled patients with heart failure who are at high risk of near-term death. It has the greatest utility in patients who have the most functional impairment.Keywords
Funding Information
- National Institute of Nursing Research (R00NR016275)
- National Institute of Nursing Research (T32NR007969)
- Visiting Nurse Service of New York (NA)
- Eugenie and Joseph Doyle Research Partnership Fund
- National Institute of Nursing Research (R00NR016275)
- National Institute of Nursing Research (T32NR007969)
This publication has 30 references indexed in Scilit:
- Revisiting the Palliative Performance Scale: Change in scores during disease trajectory predicts survivalPalliative Medicine, 2012
- Decision Making in Advanced Heart FailureCirculation, 2012
- Survival Implications of Sudden Functional Decline as a Sentinel Event Using the Palliative Performance ScaleJournal of Palliative Medicine, 2010
- Use of the Palliative Performance Scale (PPS) for End-of-Life Prognostication in a Palliative Medicine Consultation ServiceJournal of Pain and Symptom Management, 2009
- Predicting Survival with the Palliative Performance Scale in a Minority-Serving Hospice and Palliative Care ProgramJournal of Pain and Symptom Management, 2009
- A reliability and validity study of the Palliative Performance ScaleBMC Palliative Care, 2008
- Validation of the Seattle Heart Failure Model in a Community-Based Heart Failure Population and Enhancement by Adding B-Type Natriuretic PeptideThe American Journal of Cardiology, 2007
- Dying trajectories in heart failurePalliative Medicine, 2007
- The Seattle Heart Failure ModelCirculation, 2006
- Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuitionBMJ, 2000